Detalles de la búsqueda
1.
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease.
Circulation
; 117(22): 2865-74, 2008 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-18506005
2.
A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass.
J Cardiothorac Vasc Anesth
; 23(3): 324-9, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18835526
3.
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity.
Circulation
; 114(23): 2490-7, 2006 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-17101847
Resultados
1 -
3
de 3
1
Próxima >
>>